Ken Yoshii, Koichiro Suzuki, Jun Adachi, Zhenyu Piao, Eri Node, Zilai Liu, Takahiro Nagatake, Koji Hosomi, Jun Kunisawa
{"title":"Oligopeptide-binding protein A is a potential target for combating <i>Salmonella</i> infection.","authors":"Ken Yoshii, Koichiro Suzuki, Jun Adachi, Zhenyu Piao, Eri Node, Zilai Liu, Takahiro Nagatake, Koji Hosomi, Jun Kunisawa","doi":"10.3389/fimmu.2026.1943609","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>Salmonella</i> infection remains a pervasive diarrheal illness, particularly affecting populations in developing countries. The lack of an effective vaccine against non-typhoidal <i>Salmonella</i> is attributable to antigenic diversity among serotypes, incomplete understanding of protective immune mechanisms, and the difficulty in identifying conserved antigens capable of eliciting broad cross-protective immunity.</p><p><strong>Methods: </strong>To identify conserved <i>Salmonella</i> antigens, we established a <i>Salmonella</i>-specific monoclonal antibody library using heat-killed bacteria. Candidate antigens recognized by monoclonal antibodies were characterized, and their functional relevance was evaluated through analyses of bacterial growth, respiratory activity, and protective effects in a murine <i>Salmonella</i> infection model.</p><p><strong>Results: </strong>We identified L2-1H11, a monoclonal antibody that recognizes OppA, a conserved antigen present across multiple <i>Salmonella</i> serotypes. L2-1H11 was associated with suppression of bacterial growth and respiratory activity and attenuated enteritis pathology in <i>Salmonella</i>-infected mice.</p><p><strong>Conclusion: </strong>These findings identify OppA as a conserved <i>Salmonella</i> antigen and suggest that it may represent a promising target for the development of subcutaneous and oral vaccines against <i>Salmonella</i>.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"17 ","pages":"1943609"},"PeriodicalIF":7.0000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690942/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2026.1943609","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Salmonella infection remains a pervasive diarrheal illness, particularly affecting populations in developing countries. The lack of an effective vaccine against non-typhoidal Salmonella is attributable to antigenic diversity among serotypes, incomplete understanding of protective immune mechanisms, and the difficulty in identifying conserved antigens capable of eliciting broad cross-protective immunity.
Methods: To identify conserved Salmonella antigens, we established a Salmonella-specific monoclonal antibody library using heat-killed bacteria. Candidate antigens recognized by monoclonal antibodies were characterized, and their functional relevance was evaluated through analyses of bacterial growth, respiratory activity, and protective effects in a murine Salmonella infection model.
Results: We identified L2-1H11, a monoclonal antibody that recognizes OppA, a conserved antigen present across multiple Salmonella serotypes. L2-1H11 was associated with suppression of bacterial growth and respiratory activity and attenuated enteritis pathology in Salmonella-infected mice.
Conclusion: These findings identify OppA as a conserved Salmonella antigen and suggest that it may represent a promising target for the development of subcutaneous and oral vaccines against Salmonella.
期刊介绍:
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.